PHGE.AMEXBiomx INC
Form 4: BiomX Inc. Executive Acquires Stock Options
Sentiment:
SEC Form 4 Filing
Assaf Oron, Chief Business Officer of BiomX Inc., reports the acquisition of stock options.
Summary
- Assaf Oron, the Chief Business Officer of BiomX Inc., filed a Form 4.
- The form reports the acquisition of 237,500 common stock options on July 11, 2024.
- The exercise price of these options is $0.363.
- The options vest over four years, with 25% vesting on July 11, 2025, and the remainder vesting quarterly over the following three years.
- The expiration date for the options is July 11, 2034.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a standard reporting of stock option grants.
Industry Context
This is a standard SEC filing related to executive compensation and is common in the biotechnology industry.
Stakeholder Impact
- The granting of stock options can incentivize the executive to work towards increasing shareholder value.
Key Dates
| Date | Description |
|---|---|
| 07/11/2024 | Date of the transaction: acquisition of stock options. |
| 07/11/2025 | 25% of the options vest. |
| 07/11/2034 | Expiration date of the options. |
| 07/15/2024 | Date of signature on the Form 4. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.